A new analysis of a controversial study affirms something menopause experts have long argued: For many women, the benefits of short-term hormone replacement therapy outweigh their risks.
The news drops at a time when menopause is having a moment. Celebrities from Halle Berry to Gwyneth Paltrow are talking openly about their journeys, while businesses, the medical establishment and the government are waking up to the needs of the 75 million women in the US experiencing perimenopause, menopause or are postmenopausal.
But it’s a moment that must be backed by solid data, not guesswork. A recent AARP survey estimates that menopause ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.